- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Sugar acid.
Displaying page 1 of 2.
EudraCT Number: 2021-000667-74 | Sponsor Protocol Number: CV006 | Start Date*: 2021-11-30 | |||||||||||
Sponsor Name:Medisch Centrum Leeuwarden BV | |||||||||||||
Full Title: The effect of bile acid binding with colesevelam on postprandial glucose concentrations in patients after RYGB and cholecystectomy : a meal test study | |||||||||||||
Medical condition: Post Bariatric Hypoglycemia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022791-31 | Sponsor Protocol Number: D01092010AZNTG | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:University Erlangen-Nuremberg | |||||||||||||||||||||||||||||||||
Full Title: Contrast sensitivity of patients with normal tension glaucoma by application of Azarga® | |||||||||||||||||||||||||||||||||
Medical condition: The effect of AZARGA(R) on the central and spacial-temporal contrast sensitivity of patients with normal tension glaucoma will be examined. Healthy controls are required to prove the disease specif... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001263-73 | Sponsor Protocol Number: 30-01-2012_1 | Start Date*: 2012-05-25 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Involvement of corticotrophin-releasing hormone (CRH) and mucosal mast cells in stress-induced changes in intestinal permeability in healthy volunteers. | |||||||||||||
Medical condition: Stress-induced intestinal hyperpermeability | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003633-33 | Sponsor Protocol Number: MAXEPA01 | Start Date*: 2011-09-29 | |||||||||||
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: The effect of purified fish oils on glucose regulation in Congenital Hyperinsulinism of Infancy (CHI) | |||||||||||||
Medical condition: Congenital hyperinsulinism | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001216-38 | Sponsor Protocol Number: 67369 | Start Date*: 2019-06-12 | |||||||||||
Sponsor Name:Hvidovre Hospital, Region Hovedstaden | |||||||||||||
Full Title: Measurement of systemic pH and lactate in labouring women after intake of bicarbonate. | |||||||||||||
Medical condition: A successful Labour is dependent on the ability of the uterus to produce co-ordinated contractions that are of both the right duration and intensity. A failure to produce these can result in an arr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001733-86 | Sponsor Protocol Number: 1710 | Start Date*: 2014-10-15 |
Sponsor Name:Maastricht University | ||
Full Title: The effect of L-arginine on brown adipose tissue metabolism in South Asian and white Caucasian subjects | ||
Medical condition: Obesity, glucose intolerance, endothelial dysfunction | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004370-34 | Sponsor Protocol Number: POM-003 | Start Date*: 2018-04-09 | |||||||||||
Sponsor Name:Amicus Therapeutics, Inc. | |||||||||||||
Full Title: A Prospective Study in Subjects with Late-onset Pompe Disease who are Currently Being Treated with Enzyme Replacement Therapy | |||||||||||||
Medical condition: Late-onset Pompe disease (LOPD) in subjects receiving standard-of-care enzyme replacement therapy (ERT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000815-13 | Sponsor Protocol Number: DIA-644-HOL-005-I | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Technical University Munich | |||||||||||||
Full Title: Analysis of cerebral, renal, peripheral, and retinal hemodynamics in adults with type 2 diabetes before, during, and after administration of pioglitazone or placebo. | |||||||||||||
Medical condition: Considering the existing data, Actos (pioglitazone) is a promising candidate to improve hemodynamics of various vascular beds by positive effects on endothelial function. This study aims to analyse... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000755-40 | Sponsor Protocol Number: ATB200-03 | Start Date*: 2019-04-08 | |||||||||||
Sponsor Name:Amicus Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Double-blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late Onset Pompe Disease Compared With Algluc... | |||||||||||||
Medical condition: Adult Subjects With Late Onset Pompe Disease (LOPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) GB (GB - no longer in EU/EEA) SE (Completed) HU (Completed) BE (Completed) SK (Completed) ES (Completed) NL (Completed) BG (Prematurely Ended) SI (Completed) GR (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000942-39 | Sponsor Protocol Number: NL34476.068.11 | Start Date*: 2011-06-20 | ||||||||||||||||
Sponsor Name:CTMM, the Center for Translational Molecular Medicine | ||||||||||||||||||
Full Title: Effects of thyroid hormone treatment on mitochondrial function, ectopic fat accumulation, insulin sensitivity and brown adipose tissue in type 2 diabetes mellitus. | ||||||||||||||||||
Medical condition: This trial includes overweight patients with both hypothyroidism and type 2 diabetes. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004019-29 | Sponsor Protocol Number: CRACCA-2019 | Start Date*: 2021-07-15 | |||||||||||
Sponsor Name:Dipartimento di Medicina-DIMED, università di Padova | |||||||||||||
Full Title: Medical combination therapy with retinoic acid and cabergoline in ACTH-secreting pituitary adenoma: a prospective and randomized study. | |||||||||||||
Medical condition: Cushing's disease in patients in whom pituitary surgery has not been curative or in situations where it is contraindicated or refused by patient. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003873-13 | Sponsor Protocol Number: ESR-14-10613/D1690L00044 | Start Date*: 2016-02-25 | |||||||||||
Sponsor Name:Institute for the Study, Research and Education in Diabetes Mellitus and Metabolic Disorders | |||||||||||||
Full Title: Evaluation of the tubular effects of dapagliflozin using 1HNMR spectroscopy. | |||||||||||||
Medical condition: Diabetes mellitus type 2. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001115-73 | Sponsor Protocol Number: Regenerate-1 | Start Date*: 2018-06-05 | |||||||||||
Sponsor Name:Uppsala University Hospital | |||||||||||||
Full Title: A Phase I/II, 2-Arm, Open Label, Single Centre Study to Investigate the Safety and Effect of Oral GABA Therapy on β-cell Regeneration in Type 1-diabetes Patients | |||||||||||||
Medical condition: Type 1 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001793-15 | Sponsor Protocol Number: Gastro_CHU_16-1 | Start Date*: 2016-07-12 | |||||||||||
Sponsor Name:LactoResearch sprl | |||||||||||||
Full Title: PROSPECTIVE STUDY OF THE EFFICIENCY OF PROBIOTIC MIXTURE TO IMPROVE LACTOSE DIGESTION AND SYMPTOMS OF LACTOSE INTOLERANCE | |||||||||||||
Medical condition: lactose intolerance | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000954-67 | Sponsor Protocol Number: ATB200-07 | Start Date*: 2020-04-08 | |||||||||||
Sponsor Name:Amicus Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease | |||||||||||||
Medical condition: Adult Subjects With Late Onset Pompe Disease (LOPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) DE (Completed) DK (Trial now transitioned) FR (Trial now transitioned) BE (Trial now transitioned) GR (Trial now transitioned) SI (Trial now transitioned) AT (Completed) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000624-16 | Sponsor Protocol Number: LOEWE_B4 | Start Date*: 2011-11-28 | |||||||||||||||||||||
Sponsor Name:Justus Liebig Universität Gießen | |||||||||||||||||||||||
Full Title: Infertility and inflammatory urogenital diseases as a result of the metabolic syndrome Male infertility with infection and inflammation -MIBIE- | |||||||||||||||||||||||
Medical condition: infertility and inflammatory urogenital diseases as a result of the metabolic syndrome | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001381-96 | Sponsor Protocol Number: LG_T1_EGP | Start Date*: 2014-06-17 |
Sponsor Name:Medizinische Universität Graz / Endokrinologie und Stoffwechsel | ||
Full Title: A randomized, double blind, two-period cross-over trial investigating the effect of liraglutide as add on to intensive insulin treatment on the endogenous glucose production in subjects with C-pept... | ||
Medical condition: Diabetes Mellitus Type 1 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003296-34 | Sponsor Protocol Number: OTX116505 | Start Date*: 2014-01-29 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A Single Blind, Randomised, Placebo Controlled, Repeat Dose, Dose Escalating Study Investigating Safety, Tolerability Pharmacokinetics, Pharmacodynamics and the Beta-Cell Preserving Effect of Oteli... | |||||||||||||
Medical condition: NOT1DM is an autoimmune disease. This means that the immune system, the part of the body which usually helps to fight infections, mistakenly attacks cells that produce insulin in the body. Insulin ... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002023-28 | Sponsor Protocol Number: N/2015/70 | Start Date*: 2018-06-04 | |||||||||||
Sponsor Name:CHU Besançon | |||||||||||||
Full Title: Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early post-transplant period | |||||||||||||
Medical condition: Transplanté rénal à haut risque de développer un diabète de novo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001760-19 | Sponsor Protocol Number: THR-1442-C-476 | Start Date*: 2016-01-07 | |||||||||||
Sponsor Name:Theracos Sub, LLC | |||||||||||||
Full Title: A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events | |||||||||||||
Medical condition: Type II diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) PL (Completed) DK (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
